Image
Investment Banking Transactions
Date | Client | Type | Sub-Type | Amt. | Logo | Sector/Sub-Sector | Description | Tombstone Description | PSC Role | |
---|---|---|---|---|---|---|---|---|---|---|
Published | 01/28/2021 | Centrify Corporation | Mergers & Acquisitions | Buy-Side | $900.0 Million | Image
Image
|
Technology, Software | Piper Sandler served as buy-side advisor for Centrify Corporation, on sale to TPG Capital | Centrify Corporation, a portfolio company of Thoma Bravo, has been acquired by TPG Capital | Financial Advisor |
Published | 01/28/2021 | Neuronetics, Inc. | Financing, Equity Capital Markets | CMFO | $86.3 Million | Image
|
Healthcare, Med-Tech | Piper Sandler served as bookrunner for Neuronetics, Inc. on a confidentially marketed follow-on offering | Confidentially Marketed Follow-On Offering | Active Bookrunner |
Published | 01/28/2021 | Qualtrics International Inc. | Financing, Equity Capital Markets | IPO | $1.8 Billion | Image
|
Technology, Software | Piper Sandler served as co-manager for Qualtrics International Inc. on its initial public offering | Initial Public Offering | Co-Manager |
Published | 01/27/2021 | Surgalign Holdings, Inc. | Financing, Equity Capital Markets | Follow-On Offering | $43.0 Million | Image
|
Healthcare, Med-Tech | Piper Sandler served as left bookrunner for Suralign Holdings, Inc. on a follow-on offering | Follow-On Offering | Left Bookrunner |
Published | 01/26/2021 | Catalyst Biosciences, Inc. | Financing, Equity Capital Markets | CMFO | $52.8 Million | Image
|
Healthcare, Biopharma | Piper Sandler served as bookrunner for Catalyst Biosciences, Inc. on a confidentially marketed follow-on offering | Confidentially Marketed Follow-On Offering | Active Bookrunner |
Published | 01/26/2021 | Cottonwood Residential II | Mergers & Acquisitions | Fairness Opinion | Image
Image
|
Financial Services, Real Estate | Piper Sandler provided a fairness opinion for Cottonwood Residential II on sale to Cottonwood Communities, Inc. | Fairness Opinion | Financial Advisor | |
Published | 01/26/2021 | Lycra | Mergers & Acquisitions | Division Carve Out | Image
|
Energy & Power | Piper Sandler served as sell-side advisor for The Lycra Company on sale of its Houston Ship Channel Pipelines to an undisclosed buyer. | The Lycra Company has sold its Houston Ship Channel Pipelines to an undisclosed buyer | Financial Advisor | |
Published | 01/25/2021 | Gevo, Inc. | Financing, Equity Capital Markets | Registered Direct | $350.0 Million | Image
|
Consumer, Agriculture, Biorenewables & Cannabis, Energy & Power, Renewables & Clean Energy | Piper Sandler served as co-manager for Gevo, Inc. on a registered direct offering | Registered Direct | Co-Manager |
Published | 01/25/2021 | BridgeBio Pharma, Inc. | Financing, Equity Capital Markets | Convertible Offering | $650.0 Million | Image
|
Healthcare, Biopharma | Piper Sandler served as bookrunner for BridgeBio Pharma, Inc. on a convertible offering | Convertible Offering | Passive Bookrunner |
Published | 01/22/2021 | InfoSync Services, LLC. | Mergers & Acquisitions | Sell-Side | Image
Image
|
Technology, Technology Services | Piper Sandler served as sell-side advisor for InfoSync Services, LLC on sale to Staple Street Capital | InfoSync Services, LLC has been acquired by Staple Street Capital | Financial Advisor | |
Published | 01/21/2021 | Skyway Healthcare Acquisition Company | Financing, Equity Capital Markets | IPO | $230.0 Million | Image
|
Healthcare, Information-Driven Healthcare | Piper Sandler served as bookrunner for Skyway Healthcare Acquisition Company on its initial public offering | Initial Public Offering | Active Bookrunner |
Published | 01/21/2021 | Hims, Inc. | Financing, Equity Capital Markets | Advisory | Image
|
Healthcare, Information-Driven Healthcare | Piper Sandler served as financial advisor for Hims, Inc. on a SPAC merger with Oaktree Acquisition Corp. | SPAC Merger | Financial Advisor | |
Published | 01/20/2021 | Vestar Capital Partners, Inc. | Mergers & Acquisitions | Buy-Side | Image
Image
|
Consumer, Food & Beverage | Piper Sandler served as buy-side advisor for Vestar Capital Partners on acquisition of Dr. Praeger's Sensible Foods | Vestar Capital Partners has acquired Dr. Praeger's Sensible Foods | Financial Advisor | |
Published | 01/20/2021 | CytomX Therapeutics Inc. | Financing, Equity Capital Markets | Follow-On Offering | $114.9 Million | Image
|
Healthcare, Biopharma | Piper Sandler served as bookrunner for CytomX Therapeutics, Inc, on a follow-on offering | Follow-On Offering | Active Bookrunner |
Published | 01/20/2021 | National Bancorp Holdings, Inc. | Debt Capital Markets - Depositories, Real Estate & Financial Services, Financing | Subordinated Debt | $30.0 Million | Financial Services, Depositories | Piper Sandler served as sole placement agent for National Bancorp Holdings, Inc. on a $30.0 million offering of 5.375% fixed-to-floating rate subordinated notes due in 2031 | Subordinated Debt | Sole Placement Agent | |
Published | 01/20/2021 | Dyne Therapeutics, Inc. | Financing, Equity Capital Markets | Follow-On Offering | $168.0 Million | Image
|
Healthcare, Biopharma | Piper Sandler served as bookrunner for Dyne Therapeutics, Inc. on a follow-on offering | Follow-On Offering | Active Bookrunner |
Published | 01/19/2021 | Syros Pharmaceuticals, Inc. | Financing, Equity Capital Markets | CMFO | $75.6 Million | Image
|
Healthcare, Biopharma | Piper Sandler served as bookrunner for Syros Pharmaceuticals, Inc. on a confidentially marketed follow-on offering | Confidentially Marketed Follow-On Offering | Active Bookrunner |
Published | 01/19/2021 | Fulcrum Therapeutics, Inc. | Financing, Equity Capital Markets | CMFO | $50.6 Million | Image
|
Healthcare, Biopharma | Piper Sandler served as bookrunner for Fulcrum Therapeutics Inc. on a confidentially marketed follow-on offering | Confidentially Marketed Follow-On Offering | Active Bookrunner |
Published | 01/19/2021 | TCR2 Therapeutics | Financing, Equity Capital Markets | Follow-On Offering | $140.0 Million | Image
|
Healthcare, Biopharma | Piper Sandler served as bookrunner for TCR2 Therapeutics, Inc. on a follow-on offering | Follow-On Offering | Active Bookrunner |
Published | 01/17/2021 | SolmeteX, Inc. | Mergers & Acquisitions | Division Carve Out | Image
Image
Image
Image
|
Services & Industrials | Piper Sandler served as sell-side advisor for Solmetex, a division of Performance Filtration Group, a portfolio company of AVALT and Gemini Investors, on sale to Avista Capital Partners | Solmetex, a division of Performance Filtration Group, a portfolio company of AVALT and Gemini Investors, has been acquired by Avista Capital Partners | Financial Advisor |